{"transactions":[{"id":4626138,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-24T20:24:10.000Z","date":"2026-09-22","kind":"gift","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares are held by The DPB 2026 Grantor Retained Annuity Trust, of which the reporting person is the sole trustee and annuitant."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001193125-26-401078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312526401078/ownership.xml","form_type":"4"}},{"id":4626137,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-24T20:24:10.000Z","date":"2026-09-22","kind":"gift","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares transferred by the reporting person to The DPB 2026 Grantor Retained Annuity Trust, of which the reporting person is the sole trustee and annuitant."}],"balance_after":948247,"source":{"system":"sec-edgar","filing":"0001193125-26-401078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312526401078/ownership.xml","form_type":"4"}},{"id":4626136,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-24T20:24:10.000Z","date":"2026-09-22","kind":"gift","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by The KMB 2026 Grantor Retained Annuity Trust, of which the reporting person's immediate family member is the sole trustee and annuitant."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001193125-26-401078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312526401078/ownership.xml","form_type":"4"}},{"id":4626135,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-24T20:24:10.000Z","date":"2026-09-22","kind":"gift","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares transferred by the reporting person to The KMB 2026 Grantor Retained Annuity Trust, of which the reporting person's immediate family member is the sole trustee and annuitant."}],"balance_after":1098247,"source":{"system":"sec-edgar","filing":"0001193125-26-401078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312526401078/ownership.xml","form_type":"4"}},{"id":4672,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-04T20:52:26.000Z","date":"2026-09-02","kind":"other","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the issuer transferred to a family member of the reporting person for no value for estate planning purposes."}],"balance_after":1248247,"source":{"system":"sec-edgar","filing":"0001193125-26-383785","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312526383785/ownership.xml","form_type":"4"}},{"id":847954,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-11T19:03:37.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":86024,"price":6.91,"value":594425.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale."}],"balance_after":1398247,"source":{"system":"sec-edgar","filing":"0001193125-26-102652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000119312526102652/ownership.xml","form_type":"4"}},{"id":847953,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-11T19:03:37.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":205550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026."}],"balance_after":1484271,"source":{"system":"sec-edgar","filing":"0001193125-26-102652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000119312526102652/ownership.xml","form_type":"4"}},{"id":847952,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-11T19:03:37.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":51474,"price":6.91,"value":355685.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale."}],"balance_after":1278721,"source":{"system":"sec-edgar","filing":"0001193125-26-102652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000119312526102652/ownership.xml","form_type":"4"}},{"id":847951,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-11T19:03:37.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":122994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance-based restricted stock units (\"PSUs\") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026."}],"balance_after":1330195,"source":{"system":"sec-edgar","filing":"0001193125-26-102652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000119312526102652/ownership.xml","form_type":"4"}},{"id":847950,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-11T19:03:37.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10884,"price":6.91,"value":75208.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units (\"RSUs\") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale."}],"balance_after":1207201,"source":{"system":"sec-edgar","filing":"0001193125-26-102652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000119312526102652/ownership.xml","form_type":"4"}},{"id":852909,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-09T20:11:57.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":65837,"price":6.93,"value":456250.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale."}],"balance_after":1218085,"source":{"system":"sec-edgar","filing":"0001193125-26-099064","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000119312526099064/ownership.xml","form_type":"4"}},{"id":852908,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-09T20:11:57.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":395683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 395,683 restricted stock units (\"RSUs\") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1283922,"source":{"system":"sec-edgar","filing":"0001193125-26-099064","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000119312526099064/ownership.xml","form_type":"4"}},{"id":1141690,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-19T20:50:06.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":10884,"price":7.11,"value":77385.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 10, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale."}],"balance_after":888239,"source":{"system":"sec-edgar","filing":"0000950170-25-074781","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017025074781/ownership.xml","form_type":"4"}},{"id":1214387,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:50:59.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":42816,"price":7.59,"value":324973.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale."}],"balance_after":899123,"source":{"system":"sec-edgar","filing":"0000950170-25-036734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017025036734/ownership.xml","form_type":"4"}},{"id":1214386,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:50:59.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":124644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025."}],"balance_after":941939,"source":{"system":"sec-edgar","filing":"0000950170-25-036734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017025036734/ownership.xml","form_type":"4"}},{"id":1214385,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:50:59.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":29685,"price":7.59,"value":225309.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale."}],"balance_after":817295,"source":{"system":"sec-edgar","filing":"0000950170-25-036734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017025036734/ownership.xml","form_type":"4"}},{"id":1214384,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:50:59.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":80906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents performance-based restricted stock units (\"PSUs\") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025."}],"balance_after":846980,"source":{"system":"sec-edgar","filing":"0000950170-25-036734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017025036734/ownership.xml","form_type":"4"}},{"id":1214383,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:50:59.000Z","date":"2025-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":16767,"price":7.88,"value":132123.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale."}],"balance_after":766074,"source":{"system":"sec-edgar","filing":"0000950170-25-036734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017025036734/ownership.xml","form_type":"4"}},{"id":1214382,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:50:59.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":348985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 348,985 restricted stock units (\"RSUs\") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":782841,"source":{"system":"sec-edgar","filing":"0000950170-25-036734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017025036734/ownership.xml","form_type":"4"}},{"id":1579926,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-12T21:43:58.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":58826,"price":6.93,"value":407664.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":433856,"source":{"system":"sec-edgar","filing":"0000950170-24-030447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017024030447/ownership.xml","form_type":"4"}},{"id":1579925,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-12T21:43:58.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":124644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024."}],"balance_after":492682,"source":{"system":"sec-edgar","filing":"0000950170-24-030447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017024030447/ownership.xml","form_type":"4"}},{"id":1579924,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-12T21:43:58.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":104022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 104,022 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":368038,"source":{"system":"sec-edgar","filing":"0000950170-24-030447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000095017024030447/ownership.xml","form_type":"4"}},{"id":1962432,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-08T17:25:16.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":160256,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 160,256 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":264016,"source":{"system":"sec-edgar","filing":"0000899243-23-007568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000089924323007568/doc4.xml","form_type":"4"}},{"id":2117324,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-14T17:35:30.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options were granted by the Issuer pursuant to the LifeStance Health Group, Inc. 2021 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Includes an option to purchase 416,666 shares of the Issuer's common stock, subject to time-based vesting (the \"Time-Vesting Option\"). The Time-Vesting Option vests as to 25% on each of the first four anniversaries of the vesting commencement date, November 10, 2022. Includes an option to purchase 833,334 shares of the Issuer's common stock, subject to time- and performance-based vesting (the \"Performance-Vesting Option\"). The Performance-Vesting Option vests as to up to 25% on each of the first four anniversaries of the vesting commencement date, November 10, 2022. Following each anniversary of the vesting commencement date, any portion of the Performance-Vesting Option eligible to vest as of such measurement date that did not vest pursuant to the performance-based vesting criteria will be eligible to vest on a quarterly basis thereafter, subject to the same performance-based vesting criteria."}],"balance_after":1250000,"derivative":{"exercise_price":5.53,"expiration_date":"2032-11-10","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0000899243-22-035720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000089924322035720/doc4.xml","form_type":"4"}},{"id":2117323,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-14T17:35:30.000Z","date":"2022-11-10","kind":"tax_withholding","acquired":false,"shares":77072,"price":5.53,"value":426208.16,"ownership":{"direct":true},"balance_after":103760,"source":{"system":"sec-edgar","filing":"0000899243-22-035720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000089924322035720/doc4.xml","form_type":"4"}},{"id":2117322,"issuer":{"id":3936,"kind":"organization","name":"LifeStance Health Group, Inc.","symbol":"LFST"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-14T17:35:30.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":180832,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":180832,"source":{"system":"sec-edgar","filing":"0000899243-22-035720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1823690/000089924322035720/doc4.xml","form_type":"4"}},{"id":2453228,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-01-04T17:02:40.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":4362,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on October 1, 2020  were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on October 1, 2020  were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"These performance-vested restricted stock units of the Issuer that were previously reported in connection with an award granted on October 1, 2020  were disposed of in exchange for a number of time-vested restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4362},"source":{"system":"sec-edgar","filing":"0001209191-22-000949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122000949/doc4.xml","form_type":"4"}},{"id":2453227,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-04T17:02:40.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":16963,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"These unvested restricted stock units previously granted by the Issuer on March 3, 2021, which provided for a one-third vesting of shares on each of March 3, 2022, 2023 and 2024, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16963},"source":{"system":"sec-edgar","filing":"0001209191-22-000949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122000949/doc4.xml","form_type":"4"}},{"id":2453226,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-04T17:02:40.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":4383,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These unvested restricted stock units previously granted by the Issuer on October 1, 2020, which provided for vesting in equal increments on each of October 1, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These unvested restricted stock units previously granted by the Issuer on October 1, 2020, which provided for vesting in equal increments on each of October 1, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"These unvested restricted stock units previously granted by the Issuer on October 1, 2020, which provided for vesting in equal increments on each of October 1, 2022 and 2023, were disposed of in exchange for a number of restricted stock units related to shares of Centene common stock, as determined in accordance with the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4383},"source":{"system":"sec-edgar","filing":"0001209191-22-000949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122000949/doc4.xml","form_type":"4"}},{"id":2453225,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2022-01-04T17:02:40.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":1330,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the \"Merger Agreement\"), by and among the Issuer, Centene Corporation (\"Centene\") and Mayflower Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the \"Common Stock\") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the \"Merger Agreement\"), by and among the Issuer, Centene Corporation (\"Centene\") and Mayflower Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the \"Common Stock\") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-000949","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122000949/doc4.xml","form_type":"4"}},{"id":2551024,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-10-05T19:11:21.000Z","date":"2021-10-01","kind":"exercise","acquired":false,"shares":2192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Not applicable."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on October 1, 2020.  Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The remainder of 4,383 Restricted Stock Units shall vest in equal increments on October 1, 2022 and 2023, subject to earlier acceleration or forfeiture."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The remainder of 4,383 Restricted Stock Units shall vest in equal increments on October 1, 2022 and 2023, subject to earlier acceleration or forfeiture."}],"balance_after":4383,"derivative":{"exercise_price":0,"exercise_date":"2021-10-01","underlying":"Common Stock","underlying_shares":2192},"source":{"system":"sec-edgar","filing":"0001209191-21-059684","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121059684/doc4.xml","form_type":"4"}},{"id":2551023,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2021-10-05T19:11:21.000Z","date":"2021-10-01","kind":"tax_withholding","acquired":false,"shares":862,"price":94.68,"value":81614.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the portion of shares withheld by the Company in order to pay taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Closing price on NASDAQ on October 1, 2021."}],"balance_after":1330,"source":{"system":"sec-edgar","filing":"0001209191-21-059684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121059684/doc4.xml","form_type":"4"}},{"id":2551022,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2021-10-05T19:11:21.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":2192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on October 1, 2020.  Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":2192,"source":{"system":"sec-edgar","filing":"0001209191-21-059684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121059684/doc4.xml","form_type":"4"}},{"id":2807894,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-05T18:51:37.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":16963,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units shall vest in one-third increments on March 3 of each of 2022, 2023 and 2024, subject to earlier acceleration or forfeiture."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."}],"balance_after":16963,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16963},"source":{"system":"sec-edgar","filing":"0001209191-21-018375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121018375/doc4.xml","form_type":"4"}},{"id":3009768,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2020-10-09T21:18:58.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":4362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On the third anniversary of the grant date, Performance-Based Restricted Stock Units (\"PSUs\") vest based on achievement of total shareholder return (\"TSR\") performance over a three-year period beginning January 1, 2020 and ending December 31, 2022. Payout for vested PSUs ranges from 0% to 200% of the indicated number of shares, based on the Company's TSR percentile ranking compared to the TSR of the companies included in the selected market index. TSR is measured generally as the increase or decrease in the market value of the Company common stock with a deemed reinvestment of any dividends. If a participant terminates employment prior to the third anniversary of the grant date, the PSUs generally will be forfeited. PSUs have no voting rights and are generally non-transferable.  The indicated number of PSUs assumes 100% vesting, and the actual number of shares issued in settlement of the PSUs may be greater or less than the indicated number."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"(Continuation of Footnote 3) - Since the payout for PSUs can range from 0% to 200%, the maximum number of shares that could vest and be issued could be double the indicated number."}],"balance_after":4362,"derivative":{"exercise_price":0,"exercise_date":"2023-10-01","underlying":"Common Stock","underlying_shares":4362},"source":{"system":"sec-edgar","filing":"0001209191-20-054573","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919120054573/doc4a.xml","form_type":"4/A","original_submission_date":"2020-10-05"}},{"id":3009767,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-10-09T21:18:58.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":6575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units shall vest in one-third increments on October 1 of each of 2021, 2022 and 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."}],"balance_after":6575,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6575},"source":{"system":"sec-edgar","filing":"0001209191-20-054573","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919120054573/doc4a.xml","form_type":"4/A","original_submission_date":"2020-10-05"}},{"id":3015155,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2020-10-05T16:33:46.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":4362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On the third anniversary of the grant date, Performance-Based Restricted Stock Units (\"PSUs\") vest based on achievement of total shareholder return (\"TSR\") performance over a three-year period beginning January 1, 2020 and ending December 31, 2022. Payout for vested PSUs ranges from 0% to 200% of the indicated number of shares, based on the Company's TSR percentile ranking compared to the TSR of the companies included in the selected market index. TSR is measured generally as the increase or decrease in the market value of the Company common stock with a deemed reinvestment of any dividends. If a participant terminates employment prior to the third anniversary of the grant date, the PSUs generally will be forfeited. PSUs have no voting rights and are generally non-transferable.  The indicated number of PSUs assumes 100% vesting, and the actual number of shares issued in settlement of the PSUs may be greater or less than the indicated number."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"(Continuation of Footnote 3) - Since the payout for PSUs can range from 0% to 200%, the maximum number of shares that could vest and be issued could be double the indicated number."}],"balance_after":4362,"derivative":{"exercise_price":0,"exercise_date":"2023-10-01","underlying":"Common Stock","underlying_shares":4362},"source":{"system":"sec-edgar","filing":"0001209191-20-053625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919120053625/doc4.xml","form_type":"4"}},{"id":3015154,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":10162,"kind":"person","name":"Bourdon David","position":1,"cik":"0001823690","reported_name":"Bourdon David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-10-05T16:33:46.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":6598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Not applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units shall vest in one-third increments on October 1 of each of 2021, 2022 and 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Not applicable."}],"balance_after":6598,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6598},"source":{"system":"sec-edgar","filing":"0001209191-20-053625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919120053625/doc4.xml","form_type":"4"}}]}